diabetestalk.net

Medtronic Pump Upgrade

A Diabetic Product Review For Non-diabetics - The Medtronic Minimed Paradigm

A Diabetic Product Review For Non-diabetics - The Medtronic Minimed Paradigm "revel" Insulin Pump And Cgm

Sponsored By This is a review for Diabetics. If you're not a diabetic, consider this and it might help you enjoy this review. This is a product that will never affect your life. You've probably not thought about how an insulin pump works or its features. Here's a nice analogy I use to explain how diabetes works. It's called Diabetes: The Airplane Analogy. I've just received an upgrade to my insulin pump and I'm thrilled. Products like this are as important to us (diabetics) as your phone, your fancy remote control, your new DVD Player. I touch this device as often as my phone. It's attached to me 24 hours a day, it's an "external organ" to me. I've worn an insulin pump every day, all day (except showers) for the last decade. If you find this interesting, please consider helping fight diabetes: or tweeting the link I've had Medtronic pumps since 2000. I upgraded to a Paradigm with a CGM "Continuous Glucose Meter" in 2006. Last week I upgraded to a new Paradigm "Revel" Insulin Pump with a number of new features. Insulin Pumps have come a long way since they were backpacks. If you're not familiar, here's some diabetic equipment basics. Diabetes Basics I'm a Type 1 Diabetic. That means my body produces no insulin of its own and I need to get insulin from outside sources. When I eat food, the sugar in my blood goes up and isn't delivered to my cells and my body starves while marinating it its own sugar. When I take insulin, my cells unlock, sugar (fuel) is delivered to the cells, and my blood sugar values go down. Eat, go up, take insulin, go down. What's a Blood Sugar Meter do? It does just that, it measures the level of sugar in my blood. I prick my finger, usually 10 times a day or so, and I put the drop of blood on a small gauze strip that goes into a machine and gives m Continue reading >>

Insulin Pump Decision 2016

Insulin Pump Decision 2016

And the choice is… Next week I will be ordering a new pump or at least I hope I will. My decision could have been difficult, but because of the narrow time window for ordering my pump and looking at my future under Medicare, it was easy. Timing: As someone who uses a lot of technology to manage my diabetes, I satisfy my insurance deductible long before the end of the year. With my 2016 deductible satisfied, my pump will be covered at no cost to me—as long as it is shipped before the end of the year. I think I dawdled last time I purchased a pump and ended up with a warranty expiration date in December. Not great timing as I would feel more comfortable if I already had the pump in hand. My timing is also affected by my move to Medicare in April 2017. I will have individual insurance for January-March, but it will have such a high deductible that a pump purchase would essentially be out-of-pocket. If for some reason I don’t get the new pump in December, I will wait until after April 1. It is not ideal to start Medicare needing a high-ticket item and I don’t know whether I would be forced to abide by the Medicare policy of a 5-year warranty on pumps. I don’t think so because Medicare did not purchase my current pump, but you never know. Timing also affects what pump I will select. I would like the opportunity to try out the Medtronic 630G, but only if I would be eligible to upgrade to the 670G. Unfortunately I will be on Medicare by the time the 670G is released and Medicare beneficiaries are not allowed to participate in manufacturer upgrade programs. I have been told that this rule is part of anti-fraud regulations, but it truly makes no sense to me. It is not as though there is any cost to Medicare to allow me to upgrade if I pay the out-of-pocket cost (if any Continue reading >>

An Update On Medtronic’s Minimed 670g System

An Update On Medtronic’s Minimed 670g System

This morning, the Medtronic Diabetes Group held a conference call for a small group of diabetes writers to give an update on its new MiniMed 670G system, otherwise known as the world’s first hybrid closed loop system. Louis Dias, Chief Patient Officer of Medtronic Diabetes and Mike Hill, Vice President of Marketing for Medtronic’s Intensive Insulin Management Business were both on the call, as was Karrie Hawbaker, Senior Manager of Social Media. First, a recap on what the system is and what it does: The MiniMed 670G system is a combination of an insulin pump and a continuous glucose monitor. What sets it apart from its predecessors—and, for that matter, every other pump on the market—is that it can actually give you insulin. This makes it a major step forward toward the goal of a truly closed loop system. How does the 670G system work? Users must program their insulin-to-carb ratios, calibrate the system twice a day with a blood glucose reading from a finger stick, and give the system a “meal announcement” when they’re about to eat by entering the number of grams of carbohydrate that they intend to consume. The system then uses the grams of carbohydrate users have entered and their insulin-to-carb ratio to estimate an initial bolus to cover the meal. In the hours that follow, the system makes tiny tweaks to basal rates in order to get blood sugar levels as close as possible to 120 mg/dL. This means that you don’t need to enter correction boluses and that there’s no longer such thing as dual wave or square boluses—the pump is taking care of it for you. How’s it different from the most recent MiniMed pump? Medtronic Diabetes’s current top-of-the-line pump is the MiniMed 630G system with Enlite Sensor. The 530G uses something called SmartGuard™ te Continue reading >>

The Fda Approves Medtronic’s Minimed 670g Hybrid Closed Loop System

The Fda Approves Medtronic’s Minimed 670g Hybrid Closed Loop System

By Ava Runge and Adam Brown Coming to US in Spring 2017: What it is, what it isn’t, and how to get it In earlier-than-expected and very good news for people with diabetes, the Food and Drug Administration (FDA) approved Medtronic’s MiniMed 670G hybrid closed loop insulin pump and more accurate Guardian continuous glucose monitoring (CGM) sensor, Guardian Sensor 3. This news represents a major milestone for diabetes technology a little over a decade after JDRF launched the “artificial pancreas” project in 2005. It can’t be emphasized enough how exciting this development is for anyone who takes insulin and has access, since it’s definitely one step closer to the long-term goal of the artificial pancreas – the “ultimate” closed loop. Based on study results, the 670G will reduce time at dangerous high and low blood sugar levels, improve time-in-range, reduce glucose variability, bring much greater nighttime safety and target morning blood sugars, and reduce diabetes hassle. The 670G is not a “cure” and still requires some user effort (see below), but it is a very welcome advance that will make insulin therapy safer and easier for many people with diabetes – and potentially greatly improve their control. The 670G will launch in spring 2017 in the US, bringing the first system to automate basal insulin delivery to market – increasing insulin delivery when glucose is going high and decreasing insulin delivery when glucose is going low. Users still have to bolus for meals, but the system automates basal insulin delivery and targets a set blood glucose of 120 mg/dl, which is particularly effective for improving overnight blood sugars and reducing lows. The MiniMed 670G is FDA approved for people with type 1 diabetes ages 14 and over, though a pediatric Continue reading >>

Minimed 670g Upgrade Saga

Minimed 670g Upgrade Saga

I just got lied to about supplies and backorders. I got a call in early June from my rep saying I was out of warranty and due to upgrade my pump. I had asked the minimed educator at my endos office about upgrading and she said I couldnt get on priority access until this summer because I was under warranty until then, so I knew they were on the money and it was time. I said sure lets move up to the 670G. Can I do that? Oh of course, it might take a bit to get it, but youll get it by late summer. I said, " Ill take it whenever they come in, because I know they are rolling out in waves." I got a call about a month ago, mid July, saying it was in, but the CGM was back ordered. So the pump came, and then 2 weeks ago they called to check on me and if the pump had arrived. They let me know that a shipment of CGMs had arrived at Medtronic and I should get mine within a couple of days and that I should get a call from a CDE for training too. I got a call from the CDE earlier this week and she scheduled the training for next Tuesday. So today, I thought I need call and check on the shipment to make sure the CGM didnt get lost in the mail. The customer service rep said that I wasnt supposed to receive the CGM until Nov, no one had filed an exception for me and the training would just be for the pump and since I didnt upgrade to the 630, I didnt have priority. He was sorry it wasnt communicated properly to me. (I wasnt due to replace the pump through insurance until this summer, so I didnt pay for the 630 out of pocket. I waited until I was insurance eligible.) I said, Why did I get the 670G pump in the first place? I have a 530 and I have Enlite sensors that go with the CGM for it. I dont want to discontinue using a CGM to switch to the 670G without the sensors. And dont I only h Continue reading >>

Important Update On Minimed 670g Availability And The Priority Access Program

Important Update On Minimed 670g Availability And The Priority Access Program

Last fall we announced the FDA approval of the world’s first hybrid closed loop system and it was one of the proudest days of my career. After 35 years of innovation, we’re thrilled to make this revolutionary technology a reality. The MiniMed 670G® system is the most advanced insulin pump and sensor system that is personalized to your life and your diabetes. The response from the diabetes community has been incredibly touching and we thank you for all of your feedback along the way. Over the last few months we’ve been preparing our manufacturing, training and education – key steps to bringing the product to market. We know that anticipation for the new system is incredibly high and have been working as quickly as possible. But we also take our responsibility as an innovation leader seriously and are committed to taking the time needed to ensure that everyone has the best possible experience on this new system. Today we’re here to share an important update on the rollout of the MiniMed 670G system. Priority Access Program Those who purchased the MiniMed 630G system between August 10th of 2016 and April 28 of 2017 may be eligible to participate in the Priority Access program. These people have the opportunity to be among the first in line to upgrade to the MiniMed 670G system. The reason is that we believe those already using our newest pump platform will experience the easiest and quickest transition to the new system. First Step: The Customer Training Phase As we prepare to make the MiniMed 670G system available to everyone, we’ll start out with a small group of Priority Access program participants at a select number of people with diabetes and healthcare provider sites. This Customer Training Phase will allow us to validate the training and onboarding prog Continue reading >>

Update On Minimed 670g Availability

Update On Minimed 670g Availability

Today, I’m excited to share that we’re rolling out the MiniMed 670G system, beginning with those in the Priority Access program. But before we get into details, on behalf of the entire Medtronic team, I want to extend both my gratitude and my commitment to you. First, thank you for your enthusiasm for this new technology. We’re incredibly inspired by the many positive stories from those who’ve experienced the system (like Nicky and John) – either in the clinical trial or the initial Customer Training Phase – and from the anticipation expressed by our community. We are honored and humbled by the opportunity to contribute to a big change in your life with diabetes. Thank you also for your patience. We know the rollout of this first-of-its-kind technology is taking time. We’re doing our best to process orders and provide training as quickly as possible. However, the demand for the product surpassed even our own expectations. And we strongly believe that ensuring you have a great experience is more important than speed. With its exclusive SmartGuard HCL technology, the MiniMed 670G system takes a more active role in diabetes management than any technology that’s come before it. The system automatically adjusts basal insulin delivery throughout the day to maintain stable glucose levels. As a result, we’re seeing people spending more Time in Range and less time thinking about their diabetes, which is fantastic! But that also means it’s more critical than ever that each person who goes on the system and their healthcare team is comfortable. Even if it requires a little more time and patience from both of us. This is where our commitment comes in. Our first and foremost commitment to you is that we’ll do everything we can to ensure you have a great experie Continue reading >>

Tech Upgrade Program | Medtronic-diabetes.com.au

Tech Upgrade Program | Medtronic-diabetes.com.au

INTRODUCING THE TECH UPGRADE CGM SUBSCRIPTION FROM MEDTRONIC In Australia you generally get access to new technology every four years to five years (via Private health insurance). But our latest technology doesnt always come in four-year cycles; and because we dont want you to wait for access to what's new, we've created a special plan. It's called a Technology Upgrade CGM Subscription. WEVE DESIGNED AN UPGRADE PLAN FOR PEOPLE LIVING WITH T1D WHO ARE 7+ You dont just get access to the latest in pump technology now, you will also be able to access the next generation of therapy once it is available in Australia. With this Continuous Glucose Monitoring (CGM) subscription, you get the very latest in Medtronic insulin pump therapy with SmartGuardTMnow. Our MiniMed640G System1is the first one in Australia that predicts you reaching your low-level setting 30 mins before it happens and suspends basal insulin so you can prevent hypos^. Our current pump requires CGM to give you full system functionality. Medtronic are committed to advancing this technology and all future generations of Medtronic diabetes therapies will need compatible CGM to realise the benefits. (The transmitter and sensors are sold separately because insulin pumps may be covered by private health insurance). Continue reading >>

Switching From An Animas Pump Know Your Options

Switching From An Animas Pump Know Your Options

Suspend at low BG threshold feature (manual mode) Remote control for boluses from Contour Next Link meter (manual mode) Not to be used in children under 7 years of age Need to be on a minimum of eight units basal a day No share feature or mobile view for CGM data You can set a temp target of 150 for 30 minutes to 12 hours, (the default is 2 hours) Remote bolus feature only works in manual-mode Can set temporary BG target of 150 for up to two hours (keep in mind if you are an endurance athlete) 120 BG target cannot be lowered (keep in mind if you have tight control) Auto-mode does not administer meal boluses automatically Auto-mode does not allow dual wave (or extended) boluses Auto-mode may kick you out! For example: Manual-mode will kick in if ignoring a calibration request after 2.5 hours No bolus overrides/high BG corrections in auto-mode Can still use Dexcom separately in addition to pump and upload all data together with software such as Glooko Freestyle BG meter is incorporated into the PDM device Rumor has it: When the updated PDM is released (due sometime within the next year), the upgrade will be free of charge to Omnipod users Apidra is not approved with this device, users who have used it off label report many occlusion alarms Basal rates can alternate between .1 units per hour and 0 units per hour for those on less than .1 units per hour basal rate Firmware updates via device updater, allows you to plug pump into the computer once you receive an upgrade email and upgrade device from home. (The next step is to release the low suspend feature.) Rechargeable battery (lasts one week without CGM, about five days with CGM at full charge) Apidra is not approved with this device, users who have used it off label report many occlusion alarms Can still use Dexcom sep Continue reading >>

Upgrading | Medtronic

Upgrading | Medtronic

Hypo Protection the MiniMed 640G System builds on the Paradigm Veos Continuous Glucose Monitoring (CGM) capabilities to not only stop insulin delivery at a hypo/low threshold, but to stop insulin delivery when it predicts a hypo when the pump is used with an Enlite sensor. This is SmartGuard Technology and is only available from Medtronic. Convenience you can now set pre-set temporary basal rates instead of having to remember them each time you need them. You can pre-set some common boluses too, and even deliver these remotely via the linked BG meter to make life even easier without having to get your pump out. Alert volumes can be varied and are louder and CGM alarms can now be silenced completely. You still have the missed meal bolus reminder, but can also set infusion set change reminders for every 2 or 3 days now too. All things to make life easier. Design The MiniMed 640G has maximised feedback from patients to give you a sleek, modern and user friendly pump thats really quick to use and waterproof for 24 hours. And its smart, with light adjustable colour screen so you can see without glare in bright sunshine and at a glance quickly and discreetly at night. These changes have made insulin pumping easier than ever for adults, teenagers, children and anyone in between. But its how we look after you with our support and care teams that keep Medtronic users coming back. We are really proud that we try to set a Gold Standard for support, innovation and patient care. You can find out when your insulin pump is due for renewal from your Healthcare Professional. Or email us with your serial number and we can let you know. If you're coming to the end of your pumps 4 year warranty period - its usually a good idea to consider what's next > If you're coming to the end of your Continue reading >>

A Nurses Review: Medtronic 670g Insulin Pump

A Nurses Review: Medtronic 670g Insulin Pump

Medtronic’s 670 G hybrid closed loop system is the smartest insulin pump to hit the market, and people living with type 1 diabetes, including my daughter and I, have been gobbling them up. As we embark into our second week on this new system, the majority of the time I’m all in, thinking: “This is amazing, I haven’t drank juice in days,” “I need to eat something – just to eat, not because I need to balance my diabetes,” “It’s so nice not to have T1D awaken me from sleep,” or “I feel less worried about my daughter.” All remarkable thoughts. A minority of the time, I’m thinking: “Why is this pump buzzing at me again?” “This algorithm isn’t really getting me into the 120 range,” “This sensor is frustrating – my Dexcom was so simplistic to use compared to this finicky Guardian 3 sensor,” “I wish I could calibrate anytime; there’s so much button pushing and user demand.” It’s not all peaches and cream – it’s a work in progress. Patience, I tell myself. It will get to know me better. Most people report that it takes a month to love the Medtronic 670G. Truth be told: I’m one week in, and I do love it 90% of the time – as does my 15 year old. Getting Started on the 670G We personally utilized the “Pathway Program” Medtronic offered through the end of April, 2017, placing us in a virtual line for the Medtronic 670G upgrade. We were fortunate enough to have purchased our pumps less than a year prior, so our out of pocket was expensive, but not unthinkable. Word has it that 50,000 customers have ordered the Medtronic 670G pump, but customers have faced hurdles along the way with the age of their current pumps and/or lack of insurance coverage for a new pump. Owning a pump that isn’t out of warranty means we’re at Continue reading >>

Medtronic Service And Support For Animas Insulin Pump Customers

Medtronic Service And Support For Animas Insulin Pump Customers

As you may have read, this morning Animas announced its decision to close its insulin pump business, discontinuing the manufacturing and sale of all Animas® Vibe® and OneTouch Ping® insulin pumps in the US and Canada. In addition, Animas has selected Medtronic to be its partner-of-choice to support Animas customers through this time. Our top priority is to ensure that people using Animas pumps can stay on pump therapy and receive the supplies and support they need, while continuing to support our existing Medtronic customers. If you’re a Medtronic pumper, this does not impact you at all. You are, and always will be, invaluable members of our community. Whether you’ve been with us for 30 years or are a new addition to the family, we are inspired by you. You’re the reason we come to work every day excited to develop innovative products and services that help you live well and chase your dreams (whatever that may be). If you currently use an Animas insulin pump, I want to welcome you to the Medtronic family and assure you that we know the technology you use to manage your diabetes is an important, personal decision. We are here for you and committed to supporting you every step of the way. Nothing will change for you right away. However, here’s what this announcement means for you over the coming months: If your Animas pump is currently out of warranty, you can visit medtronicdiabetes.com/animas to explore your upgrade options. Please keep in mind that this arrangement does not impact Animas customers outside of the US or Canada at this time. It also does not impact those using OneTouch blood glucose meters. Again, please accept our warmest welcome to the Medtronic family. We’re honored to have the opportunity to extend to you the service and support that we Continue reading >>

Insulin Pump Options For Current Animas Customers

Insulin Pump Options For Current Animas Customers

Johnson and Johnson announced on October 5, 2017 that it is exiting the insulin pump business and will no longer make and sell the Animas Vibe and OneTouch Ping insulin pumps in the U.S. and Canada. Diabetes Daily shared what Animas pump users need to know including information on who is affected and what to do if you currently have a warranty or are out of warranty. If this affects you and you are now looking into insulin pump options, there are replacement programs from Medtronic, Tandem, and Insulet. Animas has partnered with Medtronic for this transition, but insulin pump users should realize that they do have a choice in which insulin pump they use and they should think about the features of each pump, how each pump may best aid in diabetes management, and which of the programs offered by Medtronic, Tandem, and Insulet may benefit them. People with diabetes should also contact the insulin pump company they ultimately choose as a replacement to make sure they understand all the fine print as well as speak with their insurance company to determine coverage of supplies, etc. Medtronic Medtronic’s program is available to current Animas customers. Options differ depending on when the Animas pump warranty expires. Highlights: MiniMed 670G is available for U.S. customers MiniMed 630G is available for Canadian customers Highlights for warranties expiring on or after September 30, 2019: You will transition to the MiniMed 630G insulin pump This option will be available beginning May of 2018 This will be at no cost at that time To switch to a Medtronic pump before May 2018 or the warranty expiration, you can use an in-warranty upgrade program called Switch2System Visit Medtronic’s page for Animas customers for more information. Medtronic currently has three models availab Continue reading >>

Newsflash: Medtronic Launches New Minimed 630g System

Newsflash: Medtronic Launches New Minimed 630g System

A new Medtronic insulin pump is now available in the United States, introducing a new des ign and color-screen as part of a complete makeover to these diabetes devices that have fundamentally looked the same for 30 years! Say hello to the Minimed 630G, which Medtronic announced on Thursday after receiving the FDA's Pre-Market Approval on Aug. 10. This news caught many by surprise, as the California pump-CGM company hadn't previewed this product in advance as they typically do before launches. Instead, they've focused on their forthcoming 670G hybrid closed loop system, expected to be the first-gen commercial Artficial Pancreas system to hit market in 2017. A number of users are actually upset that they weren't warned of this interim product launch, because they've recently purchased new products or upgrades. Others were holding out for the future closed loop system. So we're all wondering: Just what is this 630G that we've heard nothing about before? Remember, Medtronic got FDA approval in September 2013 for its 530G that automatically stops insulin delivery once a user crosses a certain low glucose level. That was step one in moving toward closed loop technology. Next up is their Predictive Low Glucose Suspend (PLGS) features that can anticipate oncoming hypos in advance and shut off insulin to prevent them from happening. That's built into the Minimed 640G system that hit the market outside the U.S. in early 2015. Medtronic ultimately decided it would not pursue bringing that device to the U.S., opting instead to leapfrog that model and focus on getting the first hybrid closed loop 670G to market in 2017. So now, it seems we're getting this 630G as a sort of stop-gap device in between the two D-tech generations. Here's a quick glance at the Minimed 630G: Fresh Design: Continue reading >>

Hybrid Closed Loop System.

Hybrid Closed Loop System.

NEW! The Suspend before low§ option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts. NEW! The Auto Mode‡ option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night. Watch Video View Brochure Get Started NEW! Guardian® Sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing. Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter. “This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,” “It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.” KEEP YOUR GLUCOSE IN RANGE SMARTGUARD® HCL TECHNOLOGY. Quick and easy access to your glucose and insulin information, all from the home screen. Bright color screen for easy readability - day or night. Waterproof - so you can enjoy underwater activities. Quick and easy bolus from your meter. Fewer shots than multiple daily injections. The only sensor FDA approved and trusted to control insulin dosing. Easy to insert. Know at all times where your glucose levels are trending. Click here for assistance if your insurance does not currently cover the MiniMed 670G system. * Mean Absolute Relative Difference. ** 3-4 calibrations per day required. Continue reading >>

More in insulin